EADV Virtual Congress 2020 Conference Review

In this review:

Biologics in psoriasis
Emerging therapies for AD
Emerging therapies for alopecia areata
Sunscreens: where are we going?
Neoadjuvant and adjuvant therapies in melanoma
Upcoming treatment in pruritus
Emerging therapies for vitiligo
Mirikizumab vs. secukinumab and placebo in moderate-to-severe psoriasis
Sonelokinab in moderate-to-severe chronic plaque psoriasis
CTP-543 in moderate-to-severe alopecia areata
Topical delgocitinib in chronic hand eczema
Gusacitinib in moderate-to-severe chronic hand eczema
Brepocitinib for mild-to-moderate AD
Oleogel-S10 for epidermolysis bullosa
Tapinarof cream for plaque psoriasis
Upadacitinib for moderate-to-severe AD

Please login below to download this issue (PDF)